Skip to content

The Impact of Unilateral Robotic Exoskeleton Trainer on Motor Function Recovery in Subacute Stroke Patients

The Impact of Unilateral Robotic Exoskeleton Trainer on Motor Function Recovery in Subacute Stroke Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400080941
Enrollment
Unknown
Registered
2024-02-19
Start date
2024-03-01
Completion date
Unknown
Last updated
2024-02-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

Experimental group:Unilateral Robotic Exoskeleton Trainer training
Control group:Lokomat lower limb robot training

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: ? Patients diagnosed with first-time onset hemiparesis due to stroke, including ischemic and hemorrhagic stroke, during the subacute phase after onset (5~45 days); ? Standing balance level = 1, and functional walking classification < 4. Patients should be able to wear the unilateral lower limb rehabilitation robot with the assistance of medical staff; ? Age between 18 and 75 years, both males and females are eligible; ? Stable vital signs, stable medical condition, and tolerance to low-intensity sitting and standing training; ? Weight = 100kg, height between 1.50m and 1.90m; ? MMSE (Mini-Mental State Examination) score = 24; ? Understanding of the entire experimental process, voluntary participation, and signing of the informed consent form. Passive range of motion in the hip and knee joints is not significantly restricted, and passive movement of the ankle joint can be maintained in a neutral position.

Exclusion criteria

Exclusion criteria: ? Patients with walking impairments caused by conditions such as previous spinal cord injury, amputation, severe lower limb joint diseases, or osteoarthritis, as well as those with symptoms of ataxia. ? Patients with significant diseases, including impaired or failing vital organ functions such as heart, liver, and kidneys. ? Patients with open wounds on the lower limbs. ? Patients with severe deformities in both lower limb joints. ? Those with severe cognitive impairments who are unable to cooperate and complete the experiment.

Design outcomes

Primary

MeasureTime frame
Modified Rivermead mobility index;

Secondary

MeasureTime frame
6-minute walk test;Fugl-Meyer motor function assessment-lower extremity;Functional ambulatory category;Berg balance scale;Modified Barthel index;Surface electromyography;

Countries

China

Contacts

Public ContactJiang Hanhong

West China Hospital of Sichuan University

15882374362@163.com+86 182 8036 7769

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026